Clinical Chemistry Link to Randox Laboratories Web Site
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 50: 1968-1969, 2004; 10.1373/clinchem.2004.038075
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kroll, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kroll, M. H.
Related Collections
Right arrow Laboratory Management
Right arrow General Clinical Chemistry
(Clinical Chemistry. 2004;50:1968-1969.)
© 2004 American Association for Clinical Chemistry, Inc.


Editorials

Evaluating Interference Caused by Lipemia

Martin H. Kroll

Department of Pathology and Laboratory Medicine, North Texas Veterans Affairs Medical Center, 4500 S. Lancaster Rd., 113, Dallas, TX 75216, Fax 214-857-0739, E-mail martin.kroll@med.va.gov

The first 300 words of the full text of this article appear below.

Lipemia, hemolysis, and icterus commonly interfere with laboratory tests that use optical methods (1). The interference from lipemia is fundamentally different from interferences associated with icterus (bilirubin) and hemolysis (mostly attributable to hemoglobin). In lipemia, chylomicrons and VLDL are suspended particles that scatter light, producing cloudiness or turbidity similar to that seen in milk. Lipemia may interfere in any assay that uses the transmission of light as part of the detection scheme (1).

To evaluate the susceptibility of methods to interferences from icterus or hemolysis, it is appropriate to prepare samples with added bilirubin or hemoglobin, respectively (2). By contrast, the lack of readily available, standardized materials to produce lipemic samples complicates the evaluation of lipemia. Glick et al. (2) added IntraLipid, a synthetically produced emulsion for intravenous administration, to serum to simulate lipemic samples. In this issue of Clinical Chemistry, Bornhorst et al. (3) show that samples with added IntraLipid do not perfectly mimic lipemic samples. Thus, native lipemic patient samples have falsely low results for ceruloplasmin, prealbumin, and transferrin measured by immunoturbidimetry, whereas simulated lipemic samples prepared by adding IntraLipid do not.

To understand this discrepancy and appreciate its potential occurrence with all light-based methodologies in the clinical laboratory, one must review the features of light scattering pertinent to clinical laboratory instrumentation and the physical chemical differences between naturally lipemic and IntraLipid-supplemented samples.

When electromagnetic radiation in the form of light interacts with matter, such as lipid particles, a dipole moment is induced in the particles (4). The magnitude of the dipole moment is proportional to the strength of the electric field and the polarizability of the particles (4). The particles do not need to reflect the light; instead, the phenomenon arises from . . . [Full Text of this Article]




The following articles in journals at HighWire Press have cited this article:


Home page
Clin. Chem.Home page
G. Dimeski, P. Mollee, and A. Carter
Effects of Hyperlipidemia on Plasma Sodium, Potassium, and Chloride Measurements by an Indirect Ion-Selective Electrode Measuring System
Clin. Chem., January 1, 2006; 52(1): 155 - 156.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American Association for Clinical Chemistry.